ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2022

Go back to ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2022

Immucell Corp (ICCC) Reports Q3 Loss of $0.08

November 21, 2022 4:14 PM EST

Immucell Corp (NASDAQ: ICCC) reported Q3 EPS of ($0.08), versus $0.02 reported last year. Revenue for the quarter came in at $4.8 million, versus $5.15 million reported last year.

For earnings history and earnings-related data on Immucell Corp (ICCC) click here.

... More